9 results on '"Gutner, C"'
Search Results
2. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data
- Author
-
Mataix-Cols, D, Fernández de la Cruz, L, Monzani, B, Rosenfield, D, Andersson, E, Pérez-Vigil, A, Frumento, P, de Kleine RA, Difede, J, Dunlop, Bw, Farrell, Lj, Geller, D, Gerardi, M, Guastella, Aj, Hofmann, Sg, Hendriks, Gj, Kushner, Mg, Lee, Fs, Lenze, Ej, Levinson, Ca, Mcconnell, H, Otto, Mw, Plag, J, Pollack, Mh, Ressler, Kj, Rodebaugh, Tl, Rothbaum, Bo, Scheeringa, Ms, Siewert-Siegmund, A, Smits, Jaj, Storch, Ea, Ströhle, A, Tart, Cd, Tolin, Df, van Minnen, A, Waters, Am, Weems, Cf, Wilhelm, S, Wyka, K, Davis, M, Rück, C, and the DCS Anxiety Consortium, Altemus, M, Anderson, P, Cukor, J, Finck, C, Geffken, Gr, Golfels, F, Goodman, Wk, Gutner, C, Heyman, I, Jovanovic, T, Lewin, Ab, Mcnamara, Jp, Murphy, Tk, Norrholm, S, and Thuras, P.
- Published
- 2017
3. D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: A systematic review and meta-analysis of individual participant data
- Author
-
Mataix-Cols, D., Fernández de la Cruz, L., Monzani, B., Rosenfield, D., Andersson, E., Pérez-Vigil, A., Frumento, P., Kleine, R.A. de, Difede, J., Dunlop, B.W., Farrell, L.J., Geller, D., Gerardi, M., Guastella, A.J., Hofmann, S.G., Hendriks, G.J., Kushner, M.G., Lee, F.S., Lenze, E.J., Levinson, C.A., McConnell, H., Otto, M.W., Plag, J., Pollack, M.H., Ressler, K.J., Rodebaugh, T.L., Rothbaum, B.O., Scheeringa, M.S., Siewert-Siegmund, A., Smits, J.A.J., Storch, E.A., Ströhle, A., Tart, C.D., Tolin, D.F., Minnen, A. van, Waters, A.M., Weems, C.F., Wilhelm, S., Wyka, K., Davis, M., Rück, C., Altemus, M., Anderson, P., Cukor, J., Finck, C., Geffken, G.R., Golfels, F., Goodman, W.K., Gutner, C., Heyman, I., Jovanovic, T., Lewin, A.B., McNamara, J.P., Murphy, T.K., Norrholm, S., Thuras, P., Mataix-Cols, D., Fernández de la Cruz, L., Monzani, B., Rosenfield, D., Andersson, E., Pérez-Vigil, A., Frumento, P., Kleine, R.A. de, Difede, J., Dunlop, B.W., Farrell, L.J., Geller, D., Gerardi, M., Guastella, A.J., Hofmann, S.G., Hendriks, G.J., Kushner, M.G., Lee, F.S., Lenze, E.J., Levinson, C.A., McConnell, H., Otto, M.W., Plag, J., Pollack, M.H., Ressler, K.J., Rodebaugh, T.L., Rothbaum, B.O., Scheeringa, M.S., Siewert-Siegmund, A., Smits, J.A.J., Storch, E.A., Ströhle, A., Tart, C.D., Tolin, D.F., Minnen, A. van, Waters, A.M., Weems, C.F., Wilhelm, S., Wyka, K., Davis, M., Rück, C., Altemus, M., Anderson, P., Cukor, J., Finck, C., Geffken, G.R., Golfels, F., Goodman, W.K., Gutner, C., Heyman, I., Jovanovic, T., Lewin, A.B., McNamara, J.P., Murphy, T.K., Norrholm, S., and Thuras, P.
- Abstract
Contains fulltext : 174490.pdf (publisher's version ) (Open Access), Importance: Whether and under which conditions D-cycloserine (DCS) augments the effects of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders is unclear. Objective: To clarify whether DCS is superior to placebo in augmenting the effects of cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders and to evaluate whether antidepressants interact with DCS and the effect of potential moderating variables. Data Sources: PubMed, EMBASE, and PsycINFO were searched from inception to February 10, 2016. Reference lists of previous reviews and meta-analyses and reports of randomized clinical trials were also checked. Study Selection: Studies were eligible for inclusion if they were (1) double-blind randomized clinical trials of DCS as an augmentation strategy for exposure-based cognitive behavior therapy and (2) conducted in humans diagnosed as having specific phobia, social anxiety disorder, panic disorder with or without agoraphobia, obsessive-compulsive disorder, or posttraumatic stress disorder. Data Extraction and Synthesis: Raw data were obtained from the authors and quality controlled. Data were ranked to ensure a consistent metric across studies (score range, 0-100). We used a 3-level multilevel model nesting repeated measures of outcomes within participants, who were nested within studies. Results: Individual participant data were obtained for 21 of 22 eligible trials, representing 1047 of 1073 eligible participants. When controlling for antidepressant use, participants receiving DCS showed greater improvement from pretreatment to posttreatment (mean difference, -3.62; 95% CI, -0.81 to -6.43; P = .01; d = -0.25) but not from pretreatment to midtreatment (mean difference, -1.66; 95% CI, -4.92 to 1.60; P = .32; d = -0.14) or from pretreatment to follow-up (mean difference, -2.98, 95% CI, -5.99 to 0.03; P = .05; d = -0.19). Additional analyses showed that participants ass
- Published
- 2017
4. A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review.
- Author
-
Cox J, Gutner C, Kronfli N, Lawson A, Robbins M, Nientker L, Ostawal A, Barber T, Croce D, Hardy D, Jessen H, Katlama C, Mallolas J, Rizzardini G, Alcorn K, Wohlfeiler M, and Le Fevre E
- Subjects
- Continuity of Patient Care, Delivery of Health Care, HIV Infections diagnosis, HIV Infections virology, Humans, Outcome Assessment, Health Care, Sustained Virologic Response, United Nations, Evidence-Based Medicine methods, HIV Infections drug therapy
- Abstract
To improve health outcomes in people living with HIV, adoption of evidence-based interventions (EBIs) using effective and transferable implementation strategies to optimise the delivery of healthcare is needed. ViiV Healthcare's Positive Pathways initiative was established to support the UNAIDS 90-90-90 goals. A compendium of EBIs was developed to address gaps within the HIV care continuum, yet it was unknown whether efforts existed to adapt and implement these EBIs across diverse clinical contexts. Therefore, this review sought to report on the use of implementation science in adapting HIV continuum of care EBIs. A systematic literature review was undertaken to summarise the evaluation of implementation and effectiveness outcomes, and report on the use of implementation science in HIV care. Ten databases were reviewed to identify studies (time-period: 2013-2018; geographic scope: United States, United Kingdom, France, Germany, Italy, Spain, Canada, Australia and Europe; English only publications). Studies were included if they reported on people living with HIV or those at risk of acquiring HIV and used interventions consistent with the EBIs. A broad range of study designs and methods were searched, including hybrid designs. Overall, 118 publications covering 225 interventions consistent with the EBIs were identified. These interventions were evaluated on implementation (N = 183), effectiveness (N = 81), or both outcomes (N = 39). High variability in the methodological approaches was observed. Implementation outcomes were frequently evaluated but use of theoretical frameworks was limited (N = 13). Evaluations undertaken to assess effectiveness were inconsistent, resulting in a range of measures. This review revealed extensive reporting on implementation science as defined using evaluation outcomes. However, high variability was observed in how implementation outcomes and effectiveness were defined, quantified, and reported. A more specific and consistent approach to conducting and reporting on implementation science in HIV could facilitate achievement of UNAIDS 90-90-90 targets., Competing Interests: JC, NK, KA, TB, DC, DH, HJ, CK, GR and MW received honoraria for advisory boards from ViiV Healthcare. JM received honoraria for advisory boards, lectures or research grants from Gilead, ViiV Healthcare, Roche, Janssen and Merck. CG, AL and MR work full-time at ViiV Healthcare and EF works as a part-time service provider for ViiV Healthcare. LN and AO received consulting fees from ViiV Healthcare for the conduct of the review. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Published
- 2019
- Full Text
- View/download PDF
5. Empirical Examinations of Modifications and Adaptations to Evidence-Based Psychotherapies: Methodologies, Impact, and Future Directions.
- Author
-
Stirman SW, Gamarra J, Bartlett B, Calloway A, and Gutner C
- Abstract
This review describes methods used to examine the modifications and adaptations to evidence-based psychological treatments (EBPTs), assesses what is known about the impact of modifications and adaptations to EBPTs, and makes recommendations for future research and clinical care. One hundred eight primary studies and three meta-analyses were identified. All studies examined planned adaptations, and many simultaneously investigated multiple types of adaptations. With the exception of studies on adding or removing specific EBPT elements, few studies compared adapted EBPTs to the original protocols. There was little evidence that adaptations in the studies were detrimental, but there was also limited consistent evidence that adapted protocols outperformed the original protocols, with the exception of adding components to EBPTs. Implications for EBPT delivery and future research are discussed., Competing Interests: Conflict of Interest: All authors declare that they have no conflicts of interest.
- Published
- 2017
- Full Text
- View/download PDF
6. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
- Author
-
Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Otto MW, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Scheeringa MS, Siewert-Siegmund A, Smits JAJ, Storch EA, Ströhle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Davis M, Rück C, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner C, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, and Thuras P
- Subjects
- Anxiety Disorders drug therapy, Combined Modality Therapy, Drug Synergism, Humans, Obsessive-Compulsive Disorder drug therapy, Stress Disorders, Post-Traumatic drug therapy, Antidepressive Agents therapeutic use, Anxiety Disorders therapy, Cycloserine pharmacology, Excitatory Amino Acid Agonists pharmacology, Implosive Therapy methods, N-Methylaspartate agonists, Obsessive-Compulsive Disorder therapy, Outcome Assessment, Health Care statistics & numerical data, Stress Disorders, Post-Traumatic therapy
- Abstract
Importance: Whether and under which conditions D-cycloserine (DCS) augments the effects of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders is unclear., Objective: To clarify whether DCS is superior to placebo in augmenting the effects of cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders and to evaluate whether antidepressants interact with DCS and the effect of potential moderating variables., Data Sources: PubMed, EMBASE, and PsycINFO were searched from inception to February 10, 2016. Reference lists of previous reviews and meta-analyses and reports of randomized clinical trials were also checked., Study Selection: Studies were eligible for inclusion if they were (1) double-blind randomized clinical trials of DCS as an augmentation strategy for exposure-based cognitive behavior therapy and (2) conducted in humans diagnosed as having specific phobia, social anxiety disorder, panic disorder with or without agoraphobia, obsessive-compulsive disorder, or posttraumatic stress disorder., Data Extraction and Synthesis: Raw data were obtained from the authors and quality controlled. Data were ranked to ensure a consistent metric across studies (score range, 0-100). We used a 3-level multilevel model nesting repeated measures of outcomes within participants, who were nested within studies., Results: Individual participant data were obtained for 21 of 22 eligible trials, representing 1047 of 1073 eligible participants. When controlling for antidepressant use, participants receiving DCS showed greater improvement from pretreatment to posttreatment (mean difference, -3.62; 95% CI, -0.81 to -6.43; P = .01; d = -0.25) but not from pretreatment to midtreatment (mean difference, -1.66; 95% CI, -4.92 to 1.60; P = .32; d = -0.14) or from pretreatment to follow-up (mean difference, -2.98, 95% CI, -5.99 to 0.03; P = .05; d = -0.19). Additional analyses showed that participants assigned to DCS were associated with lower symptom severity than those assigned to placebo at posttreatment and at follow-up. Antidepressants did not moderate the effects of DCS. None of the prespecified patient-level or study-level moderators was associated with outcomes., Conclusions and Relevance: D-cycloserine is associated with a small augmentation effect on exposure-based therapy. This effect is not moderated by the concurrent use of antidepressants. Further research is needed to identify patient and/or therapy characteristics associated with DCS response.
- Published
- 2017
- Full Text
- View/download PDF
7. Linguistic correlates of social anxiety disorder.
- Author
-
Hofmann SG, Moore PM, Gutner C, and Weeks JW
- Subjects
- Adolescent, Case-Control Studies, Emotions, Female, Humans, Male, Psychiatric Status Rating Scales statistics & numerical data, Speech, Young Adult, Anxiety Disorders psychology, Linguistics statistics & numerical data, Social Behavior
- Abstract
The goal of this study was to examine the linguistic correlates of social anxiety disorder (SAD). Twenty-four individuals with SAD (8 of them with a generalised subtype) and 21 non-anxious controls were asked to give speeches in front of an audience. The transcribed speeches were examined for the frequency of negations, I-statements, we-statements, negative emotion words, and positive emotion words. During their speech, individuals with either SAD subtype used positive emotion words more often than controls. No significant differences were observed in the other linguistic categories. These results are discussed in the context of evolutionary and cognitive perspectives of SAD.
- Published
- 2012
- Full Text
- View/download PDF
8. Rejection sensitivity mediates the relationship between social anxiety and body dysmorphic concerns.
- Author
-
Fang A, Asnaani A, Gutner C, Cook C, Wilhelm S, and Hofmann SG
- Subjects
- Adolescent, Female, Humans, Interpersonal Relations, Male, Young Adult, Anxiety psychology, Body Dysmorphic Disorders psychology, Body Image, Phobic Disorders psychology, Rejection, Psychology, Social Behavior
- Abstract
The goal of this study was to examine the role of rejection sensitivity in the relationship between social anxiety and body dysmorphic concerns. To test our hypothesis that rejection sensitivity mediates the link between social anxiety and body dysmorphic concerns, we administered self-report questionnaires to 209 student volunteers. Consistent with our prediction, rejection sensitivity partially mediated the relationship between social anxiety symptoms and body dysmorphic concerns. The implications of the overlap between these constructs are discussed., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
9. Alcohol problems and posttraumatic stress disorder in female crime victims.
- Author
-
Kaysen D, Simpson T, Dillworth T, Larimer ME, Gutner C, and Resick PA
- Subjects
- Adolescent, Adult, Alcoholism psychology, Comorbidity, Female, Humans, Longitudinal Studies, Middle Aged, Multivariate Analysis, Rape psychology, Stress Disorders, Post-Traumatic psychology, United States epidemiology, Alcoholism epidemiology, Crime Victims psychology, Stress Disorders, Post-Traumatic epidemiology, Violence psychology
- Abstract
Comorbidity between alcohol use and posttraumatic stress disorder (PTSD) has been well documented. However, there are few longitudinal studies with acute trauma samples. The present study examined symptoms of alcohol use disorders (AUDs) and PTSD longitudinally after assault. Female sexual (n = 69) and physical assault victims (n = 39) were assessed 2 to 4 weeks and 3 months post trauma. Women who had lifetime AUD had higher intrusive and avoidance symptoms than those who did not have AUD. Women who had any alcohol problems had higher PTSD symptoms. Participants who had alcohol problems had the same pattern of symptom recovery as those who did not have alcohol problems but remained more symptomatic over the 3 months. These findings suggest that early intervention strategies for women who have previous histories of alcohol problems and seek medical attention early post trauma may be indicated.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.